Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering
Electra Therapeutics, a late-stage biopharmaceutical company specializing in precision medicines for immune-mediated diseases and cancer, announced the pricing of its upsized initial public offering (IPO) of 23.3 million shares at $15 per share, expected to raise $350 million in gross proceeds. Shares will trade on Nasdaq under ticker symbol ETRA, …